Table of Content

1 Oral Antibiotics Market Overview
1.1 Product Overview and Scope of Oral Antibiotics
1.2 Oral Antibiotics Segment by Type
1.2.1 Global Oral Antibiotics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Beta Lactam and Beta Lactamase Inhibitors
1.2.3 Quinolone
1.2.4 Macrolide
1.3 Oral Antibiotics Segment by Application
1.3.1 Oral Antibiotics Sales Comparison by Application: (2021-2027)
1.3.2 Respiratory Tract Infection
1.3.3 Dental Therapy
1.4 Global Oral Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Oral Antibiotics Revenue 2016-2027
1.4.2 Global Oral Antibiotics Sales 2016-2027
1.4.3 Oral Antibiotics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Oral Antibiotics Market Competition by Manufacturers
2.1 Global Oral Antibiotics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Oral Antibiotics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oral Antibiotics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oral Antibiotics Manufacturing Sites, Area Served, Product Type
2.5 Oral Antibiotics Market Competitive Situation and Trends
2.5.1 Oral Antibiotics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Antibiotics Players Market Share by Revenue
2.5.3 Global Oral Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oral Antibiotics Retrospective Market Scenario by Region
3.1 Global Oral Antibiotics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Oral Antibiotics Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Oral Antibiotics Market Facts & Figures by Country
3.3.1 North America Oral Antibiotics Sales by Country
3.3.2 North America Oral Antibiotics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oral Antibiotics Market Facts & Figures by Country
3.4.1 Europe Oral Antibiotics Sales by Country
3.4.2 Europe Oral Antibiotics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Antibiotics Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Antibiotics Sales by Region
3.5.2 Asia Pacific Oral Antibiotics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oral Antibiotics Market Facts & Figures by Country
3.6.1 Latin America Oral Antibiotics Sales by Country
3.6.2 Latin America Oral Antibiotics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Antibiotics Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Antibiotics Sales by Country
3.7.2 Middle East and Africa Oral Antibiotics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oral Antibiotics Historic Market Analysis by Type
4.1 Global Oral Antibiotics Sales Market Share by Type (2016-2021)
4.2 Global Oral Antibiotics Revenue Market Share by Type (2016-2021)
4.3 Global Oral Antibiotics Price by Type (2016-2021)

5 Global Oral Antibiotics Historic Market Analysis by Application
5.1 Global Oral Antibiotics Sales Market Share by Application (2016-2021)
5.2 Global Oral Antibiotics Revenue Market Share by Application (2016-2021)
5.3 Global Oral Antibiotics Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Laboratories Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 F.Hoffmann-La Roche
6.3.1 F.Hoffmann-La Roche Corporation Information
6.3.2 F.Hoffmann-La Roche Description and Business Overview
6.3.3 F.Hoffmann-La Roche Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 F.Hoffmann-La Roche Product Portfolio
6.3.5 F.Hoffmann-La Roche Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Merck and Corporation
6.5.1 Merck and Corporation Corporation Information
6.5.2 Merck and Corporation Description and Business Overview
6.5.3 Merck and Corporation Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merck and Corporation Product Portfolio
6.5.5 Merck and Corporation Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Mylan Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Sanofi Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Corporation Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Oral Antibiotics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Teva Pharmaceutical Industries Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates

7 Oral Antibiotics Manufacturing Cost Analysis
7.1 Oral Antibiotics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Antibiotics
7.4 Oral Antibiotics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Antibiotics Distributors List
8.3 Oral Antibiotics Customers

9 Oral Antibiotics Market Dynamics
9.1 Oral Antibiotics Industry Trends
9.2 Oral Antibiotics Growth Drivers
9.3 Oral Antibiotics Market Challenges
9.4 Oral Antibiotics Market Restraints

10 Global Market Forecast
10.1 Oral Antibiotics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Antibiotics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Oral Antibiotics by Type (2022-2027)
10.2 Oral Antibiotics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Antibiotics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Oral Antibiotics by Application (2022-2027)
10.3 Oral Antibiotics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Antibiotics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Oral Antibiotics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Antibiotics Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Oral Antibiotics Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Oral Antibiotics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Oral Antibiotics Covered in This Study
Table 5. Global Oral Antibiotics Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Oral Antibiotics Sales Share by Manufacturers (2016-2021)
Table 7. Global Oral Antibiotics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Oral Antibiotics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Oral Antibiotics Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Oral Antibiotics Manufacturing Sites and Area Served
Table 11. Manufacturers Oral Antibiotics Product Type
Table 12. Global Oral Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oral Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Antibiotics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oral Antibiotics Sales by Region (2016-2021) & (K Units)
Table 16. Global Oral Antibiotics Sales Market Share by Region (2016-2021)
Table 17. Global Oral Antibiotics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Oral Antibiotics Sales by Country (2016-2021) & (K Units)
Table 19. North America Oral Antibiotics Sales Market Share by Country (2016-2021)
Table 20. North America Oral Antibiotics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Oral Antibiotics Revenue Market Share by Country (2016-2021)
Table 22. Europe Oral Antibiotics Sales by Country (2016-2021) & (K Units)
Table 23. Europe Oral Antibiotics Sales Market Share by Country (2016-2021)
Table 24. Europe Oral Antibiotics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Oral Antibiotics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Oral Antibiotics Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Oral Antibiotics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Oral Antibiotics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Oral Antibiotics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Oral Antibiotics Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Oral Antibiotics Sales Market Share by Country (2016-2021)
Table 32. Latin America Oral Antibiotics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Oral Antibiotics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Oral Antibiotics Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Oral Antibiotics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Oral Antibiotics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Oral Antibiotics Revenue Market Share by Country (2016-2021)
Table 38. Global Oral Antibiotics Sales (K Units) by Type (2016-2021)
Table 39. Global Oral Antibiotics Sales Market Share by Type (2016-2021)
Table 40. Global Oral Antibiotics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Oral Antibiotics Revenue Share by Type (2016-2021)
Table 42. Global Oral Antibiotics Price (US$/Unit) by Type (2016-2021)
Table 43. Global Oral Antibiotics Sales (K Units) by Application (2016-2021)
Table 44. Global Oral Antibiotics Sales Market Share by Application (2016-2021)
Table 45. Global Oral Antibiotics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Oral Antibiotics Revenue Share by Application (2016-2021)
Table 47. Global Oral Antibiotics Price (US$/Unit) by Application (2016-2021)
Table 48. Abbott Laboratories Corporation Information
Table 49. Abbott Laboratories Description and Business Overview
Table 50. Abbott Laboratories Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Abbott Laboratories Oral Antibiotics Product
Table 52. Abbott Laboratories Recent Developments/Updates
Table 53. Allergan Corporation Information
Table 54. Allergan Description and Business Overview
Table 55. Allergan Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Allergan Oral Antibiotics Product
Table 57. Allergan Recent Developments/Updates
Table 58. F.Hoffmann-La Roche Corporation Information
Table 59. F.Hoffmann-La Roche Description and Business Overview
Table 60. F.Hoffmann-La Roche Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. F.Hoffmann-La Roche Oral Antibiotics Product
Table 62. F.Hoffmann-La Roche Recent Developments/Updates
Table 63. GlaxoSmithKline Corporation Information
Table 64. GlaxoSmithKline Description and Business Overview
Table 65. GlaxoSmithKline Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. GlaxoSmithKline Oral Antibiotics Product
Table 67. GlaxoSmithKline Recent Developments/Updates
Table 68. Merck and Corporation Corporation Information
Table 69. Merck and Corporation Description and Business Overview
Table 70. Merck and Corporation Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Merck and Corporation Oral Antibiotics Product
Table 72. Merck and Corporation Recent Developments/Updates
Table 73. Mylan Corporation Information
Table 74. Mylan Description and Business Overview
Table 75. Mylan Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Mylan Oral Antibiotics Product
Table 77. Mylan Recent Developments/Updates
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Business Overview
Table 80. Novartis Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Novartis Oral Antibiotics Product
Table 82. Novartis Recent Developments/Updates
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Business Overview
Table 85. Pfizer Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Pfizer Oral Antibiotics Product
Table 87. Pfizer Recent Developments/Updates
Table 88. Sanofi Corporation Information
Table 89. Sanofi Description and Business Overview
Table 90. Sanofi Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Sanofi Oral Antibiotics Product
Table 92. Sanofi Recent Developments/Updates
Table 93. Teva Pharmaceutical Industries Corporation Information
Table 94. Teva Pharmaceutical Industries Description and Business Overview
Table 95. Teva Pharmaceutical Industries Oral Antibiotics Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Teva Pharmaceutical Industries Oral Antibiotics Product
Table 97. Teva Pharmaceutical Industries Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Oral Antibiotics Distributors List
Table 101. Oral Antibiotics Customers List
Table 102. Oral Antibiotics Market Trends
Table 103. Oral Antibiotics Growth Drivers
Table 104. Oral Antibiotics Market Restraints
Table 105. Global Oral Antibiotics Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Oral Antibiotics Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Oral Antibiotics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Oral Antibiotics Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Oral Antibiotics Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Oral Antibiotics Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Oral Antibiotics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Oral Antibiotics Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Oral Antibiotics Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Oral Antibiotics Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Oral Antibiotics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Oral Antibiotics Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Antibiotics
Figure 2. Global Oral Antibiotics Market Share by Type in 2020 & 2027
Figure 3. Beta Lactam and Beta Lactamase Inhibitors Product Picture
Figure 4. Quinolone Product Picture
Figure 5. Macrolide Product Picture
Figure 6. Global Oral Antibiotics Market Share by Application in 2020 & 2027
Figure 7. Respiratory Tract Infection
Figure 8. Dental Therapy
Figure 9. Global Oral Antibiotics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Oral Antibiotics Market Size 2016-2027 (US$ Million)
Figure 11. Global Oral Antibiotics Sales 2016-2027 (K Units)
Figure 12. Global Oral Antibiotics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Oral Antibiotics Sales Share by Manufacturers in 2020
Figure 14. Global Oral Antibiotics Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Oral Antibiotics Players: Market Share by Revenue in 2020
Figure 16. Oral Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Oral Antibiotics Sales Market Share by Region (2016-2021)
Figure 18. Global Oral Antibiotics Sales Market Share by Region in 2020
Figure 19. Global Oral Antibiotics Revenue Market Share by Region (2016-2021)
Figure 20. Global Oral Antibiotics Revenue Market Share by Region in 2020
Figure 21. U.S. Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Oral Antibiotics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Oral Antibiotics by Type (2016-2021)
Figure 46. Sales Market Share of Oral Antibiotics by Application (2016-2021)
Figure 47. Sales Market Share of Oral Antibiotics by Application in 2020
Figure 48. Revenue Share of Oral Antibiotics by Application (2016-2021)
Figure 49. Revenue Share of Oral Antibiotics by Application in 2020
Figure 50. Manufacturing Cost Structure of Oral Antibiotics
Figure 51. Manufacturing Process Analysis of Oral Antibiotics
Figure 52. Oral Antibiotics Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed